Olshan Frome Wolosky represented ImmunityBio in the transaction. ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, has entered into a definitive agreement to acquire a leasehold interest in 409,000...
ImmunityBio’s Acquisition of State-of-the-Art Manufacturing Plant in New York
Nightingale and Wafra’s $220 Million Acquisition of a Korein Family’s Property
Olshan Frome Wolosky LLP represented the Korein Family in the transaction. The Korein Family executed the sale of 111 Wall Street for $220 million to a...